STRS Ohio’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,500
Closed -$9K 2050
2022
Q4
$9K Hold
2,500
﹤0.01% 1926
2022
Q3
$15K Hold
2,500
﹤0.01% 1946
2022
Q2
$16K Hold
2,500
﹤0.01% 1973
2022
Q1
$20K Sell
2,500
-17,300
-87% -$140K ﹤0.01% 2047
2021
Q4
$306K Hold
19,800
﹤0.01% 1610
2021
Q3
$445K Buy
19,800
+13,600
+219% +$286K ﹤0.01% 1552
2021
Q2
$121K Buy
+6,200
New +$141K ﹤0.01% 1934

Other funds holding SANA

STRS Ohio's SANA Position: Q1 2023 in Review

STRS Ohio sold out of Sana Biotechnology (SANA) in Q1 2023, closing a stake of 2,500 shares — an estimated $9K sold.

STRS Ohio first reported a position in SANA in Q2 2021 and held it in 7 quarters. The position peaked at $445K in Q3 2021. 120 funds tracked by Wall St. Rank hold SANA as of Q1 2023.

  • STRS Ohio reported no remaining Sana Biotechnology position as of Q1 2023 after selling out during the quarter.
  • STRS Ohio sold 2,500 Sana Biotechnology shares in Q1 2023, an estimated $9K.
  • STRS Ohio first reported a position in Sana Biotechnology in Q2 2021 and held it in 7 quarters.
  • STRS Ohio's Sana Biotechnology position peaked at $445K in Q3 2021.
  • 120 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2023.

Based on STRS Ohio's 13F filing for Q1 2023, filed 27 Apr 2023.